Suven Pharmaceuticals

BSE: 543064 | NSE: SUVENPHAR
Suven Pharmaceuticals (CIN: L24299TG2018PLC128171) operates in the Pharmaceuticals industry and has been listed in the stock market since 9th Mar 2020. It currents trades on NSE with symbol SUVENPHAR and on BSE with scrip code 543064.
The registered office of the company is 8-2-334, SDE Serene Chambers, 3rd Floor, Road No. 5, Avenue 7, Banjara Hills,Hyderabad,Telangana,500034.

The management team of Suven Pharmaceuticals is led by Mr. VENKATESWARLU JASTI who is the Executive Director-Chairperson-MD. Other members of the management team consist of Mr. GOVINDA PRASAD DASU (Designation:Non-Executive - Independent Director), Mr. SRIVARI CHANDRASEKHAR (Designation:Non-Executive - Independent Director), Mrs. DEEPANWITA CHATTOPADHYAY (Designation:Non-Executive - Independent Director), Mr. P Subba Rao (Designation:Chief Financial Officer), Mr. VENKATA RAMUDU JASTHI (Designation:Non-Executive - Non Independent Director), Mr. JERRY JEYASINGH (Designation:Non-Executive - Non Independent Director), Dr. Vajja Sambasiva Rao (Designation:Independent Director), K. Hanumantha Rao (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Suven Pharmaceuticals is as below -

BSE 538.15 -2 (-0.37%)

BSE

538.15 -2 (-0.37%)
Symbol is not Traded Today for NSE

Stock Price Chart

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.